RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION • NOT FOR VETERINARY USE
BATCH VAULT™

Lot-Specific Documentation

Review documentation status and search released F3 lots for available batch records and analytical documentation.

Batch Vault is preparing for inventory release.

Supplier-provided Certificates of Analysis have been received for seven products in the planned catalog. Their authenticity, correspondence to incoming inventory, and supporting analytical information have not yet been independently verified.

Searchable F3 lot records will appear only after physical inventory is received, reviewed, assigned an internal lot number, and released. No preliminary supplier document is represented as an approved F3 inventory record.

Once implemented for released inventory, vial labels will identify the applicable F3 SKU and lot number and provide access to associated Batch Vault documentation.
Example format only: F3-GHK50-2609-A. Actual F3 lot numbers will be assigned after inventory receipt.
DOCUMENTATION STATUS

Incoming supplier records

The following status reflects documents supplied before physical inventory receipt. These are not independently verified F3 lot releases.

SUPPLIER COA RECEIVED

Retatrutide

30 mg

Supplier batch: BATCH-30032

Supplier-reported purity: 99.326%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

Tirzepatide

10 mg

Supplier batch: BATCH-1019

Supplier-reported purity: 99.449%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

BPC-157

10 mg

Supplier batch: BATCH-10765

Supplier-reported purity: 99.446%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

Ipamorelin

5 mg

Supplier batch: BATCH-51233

Supplier-reported purity: 99.831%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

BPC-157 / TB-500

5 mg / 5 mg

Supplier batch: BATCH-10832

Supplier-reported purity: 99.268%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

CJC-1295 No DAC / Ipamorelin

5 mg / 5 mg

Supplier batch: BATCH-1049

Supplier-reported purity: 99.547%. Verification pending.

NOT RELEASED
SUPPLIER COA RECEIVED

GHK-Cu

50 mg

Supplier batch: BATCH-5010

Supplier-reported purity: 99.847%. Verification pending.

NOT RELEASED
DOCUMENTATION PENDING

Semaglutide

5 mg

No supplier COA currently on file.

NOT RELEASED
DOCUMENTATION PENDING

TB-500

5 mg

No supplier COA currently on file for standalone TB-500.

NOT RELEASED
Documentation notice: Reported purity figures are transcribed from supplier-provided documents. F3 Biosciences has not independently authenticated those reports or confirmed that the listed supplier batches correspond to received inventory. These figures are not independent F3 testing results.
TRACEABILITY MODEL

Vial → lot → documentation.

F3's planned lot convention is designed to keep the physical product, internal inventory record, and customer-facing documentation tied together.

Release record structure

  • F3 catalog SKU
  • Supplier/source lot retained internally
  • F3 lot assignment
  • COA and analytical-document review
  • Release / quarantine status
  • QR-linked Batch Vault record